Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.
Smith, David B
Lind, Michael J
Chopra, M P
Fitzgerald, M D
AffiliationCRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, England.